Home/Pipeline/gammaCore Sapphire CV

gammaCore Sapphire CV

Emergency Use (Condition unspecified)

Emergency Use AuthorizationEUA Received

Key Facts

Indication
Emergency Use (Condition unspecified)
Phase
Emergency Use Authorization
Status
EUA Received
Company

About electroCore

Founded in 2005, electroCore is a leader in non-invasive neuromodulation, developing and commercializing its gammaCore nVNS platform. The company has achieved FDA clearances, CE marks, and other international approvals for its reusable medical device, generating revenue while expanding its clinical pipeline into new indications like PTSD and metabolic disorders. With a strong intellectual property portfolio of over 200 patents and a seasoned leadership team, electroCore aims to establish nVNS as a foundational therapy across multiple therapeutic areas.

View full company profile